Training and Resources
KEYTRUDA® (pembrolizumab) in non-small cell lung cancer (NSCLC)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]
KEYTRUDA® plus chemotherapy
![](https://www.msdconnect.co.uk/wp-content/uploads/sites/53/2023/03/dr-carles-escrui-video@2x.jpg)
Discover what 5-year follow up data might mean for your eligible Squamous and non-Squamous mNSCLC patients?
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
![](https://www.msdconnect.co.uk/wp-content/uploads/sites/53/2022/04/msdc-dr-r-shah-kn189-thumbnail.png)
KEYNOTE-189: what the 4-year follow-up data might mean for your eligible non-squamous mNSCLC patients
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
![Click here to download the Take a closer look at your untreated PD-L1 negative mNSCLC patients: meet Bill PDF](https://www.msdconnect.co.uk/wp-content/uploads/sites/53/2022/08/MSDC_Keytruda_Bill_resoure_thumbnail@2x.png)
Take a closer look at your untreated PD-L1 non-expressing mNSCLC patients: meet Bill
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
![Click here to download the Take a closer look at your untreated squamous PD-L1 negative mNSCLC patients: Meet Bob PDF](https://www.msdconnect.co.uk/wp-content/uploads/sites/53/2022/08/msdc-keytruda-bob-asset-thumbnail.png)
Take a closer look at your untreated squamous PD-L1 negative mNSCLC patients: meet Bob
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
![Click here to download A guide to managing your metastatic non-small cell lung cancer patient on KEYTRUDA plus chemotherapy](https://www.msdconnect.co.uk/wp-content/uploads/sites/53/2021/11/msdc_keytruda_GB-PDO-00788_poster.png)
A guide to managing your metastatic non-small cell lung cancer patients on KEYTRUDA® (pembrolizumab) plus chemotherapy
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
KEYTRUDA® monotherapy
KEYTRUDA® in early stage NSCLC
Patient management
![](https://www.msdconnect.co.uk/wp-content/uploads/sites/53/2022/04/img-lrg-keylearning-hub-link@2x.jpg)
KEYLearning Hub: digestible peer-to-peer videos on managing mNSCLC patients on KEYTRUDA® plus chemotherapy
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
![Click here to download A guide to managing your metastatic non-small cell lung cancer patient on KEYTRUDA plus chemotherapy](https://www.msdconnect.co.uk/wp-content/uploads/sites/53/2021/11/msdc_keytruda_GB-PDO-00788_poster.png)
A guide to managing your metastatic non-small cell lung cancer patients on KEYTRUDA® (pembrolizumab) plus chemotherapy
Prescribing Information (Great Britain) &
Prescribing Information (Northern Ireland)
[External links]
More information about KEYTRUDA® (pembrolizumab) in advanced NSCLC
Supporting documentation
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website